InMed-logo-01

Filings

Form TypeForm DescriptionFiling DateReport DateView Report
10-KAnnual report [Section 13 and 15(d), not S-K Item 405]2025-09-232025-06-30
8-KCurrent report2025-09-232025-09-23
8-KCurrent report2025-09-232025-09-23
8-KCurrent report2025-09-082025-09-05
424B3Prospectus [Rule 424(b)(3)]2025-08-05
EFFECTNotice of Effectiveness2025-08-01
S-1/AGeneral form for registration of securities under the Securities Act of 1933 - amended2025-08-01
8-KCurrent report2025-07-282025-07-28
S-1General form for registration of securities under the Securities Act of 19332025-07-09
8-KCurrent report2025-06-302025-06-24
8-KCurrent report2025-06-242025-06-24
8-KCurrent report2025-06-132025-06-12
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material2025-05-29
DEF 14AOther definitive proxy statements2025-05-162025-06-13
8-KCurrent report2025-05-132025-05-12
10-QQuarterly report [Sections 13 or 15(d)]2025-05-122025-03-31
PRE 14AOther preliminary proxy statements2025-04-292025-04-29
8-KCurrent report2025-04-252025-04-25
8-KCurrent report2025-04-082025-04-04
SCHEDULE 13G/AForm - SCHEDULE 13G - amended2025-04-02
8-KCurrent report2025-02-142025-02-10
8-KCurrent report2025-02-132025-02-12
10-QQuarterly report [Sections 13 or 15(d)]2025-02-122024-12-31
4Statement of changes in beneficial ownership of securities2025-02-032025-01-11
8-KCurrent report2025-02-032025-02-03
8-KCurrent report2025-01-222025-01-22
8-KCurrent report2025-01-212025-01-21
SCHEDULE 13G/AForm - SCHEDULE 13G - amended2025-01-03
424B3Prospectus [Rule 424(b)(3)]2025-01-02
EFFECTNotice of Effectiveness2024-12-31

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*